Persistent reduction of B virus (Herpesvirus simiae) seropositivity in rhesus macaques acquired for a study of renal allograft tolerance.
One hundred and two rhesus macaques were used in a study of renal allograft tolerance. Each animal was monitored serologically more than one time to determine its B virus (Herpesvirus simiae) antibody status. The follow-up period for some individuals was 3 years, extending from 1986 to 1989. The accumulated test results eventually provided an opportunity to retrospectively support a contention that a small research colony of rhesus macaques could become and remain B virus seronegative if the animals were housed individually, monitored periodically, acquired only if they were seronegative, and culled if they converted to positive status. It was also possible that the test results might disclose useful information about the influence of acute immunosuppression on the reliability of determining B virus antibody status by serologic methods, and help formulate guidelines for selecting donor-recipient pairs. A review of the serologic test results disclosed that antibody status before the initiation of experimental therapy, and subsequent seroreactivity, did not change throughout the experimental lifetime of 92 monkeys. The few exceptions were six juveniles that lost detectable antibody, and four other juveniles that converted to positive. Preliminary data suggested that total lymphoid irradiation (TLI) and splenectomy were associated with the loss of detectable antibody; however, further study is needed to establish the validity and significance of this association. No other unexpected or unexplained results were associated with concomitant periods of acute immunosuppression. The number of seropositive animals in the colony was reduced to three through attrition and culling by the end of 1989.(ABSTRACT TRUNCATED AT 250 WORDS)
Olson
L C
LC
Department of Comparative Medicine, School of Medicine, East Carolina University, NC 27858.
Pryor
W H
WH
Thomas
J M
JM
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D006566:Herpesviridae Infections / Q000276:immunology / Q000517:prevention & control; D006568:Herpesvirus 1, Cercopithecine / Q000276:immunology*; D007108:Immune Tolerance; D016030:Kidney Transplantation / Q000276:immunology; D008253:Macaca mulatta / Q000382:microbiology*; D008297:Male; D013997:Time Factors; D014184:Transplantation, Homologous
D000914:Antibodies, Viral